Sunshine Biopharma (SBFM) Soars 400% Last Month: Time to Sell?

If you are in the hunt for pharmaceutical stocks then it might be worthwhile to take a closer look at the Sunshine Biopharma, Inc. (OTC: SBFM) stock. It was one of the biggest gainers in the pharmaceutical sector in January and clocked gains of as big as 400% in the month. More importantly, the stock also received a significant boost last week and that could be another reason for the continued rally in the Sunshine stock.

The company, which is involved in the development as well as commercialization of anti-viral and oncology products, announced last week that it submitted an application for uplisting to the OTCQB. At this point, the Sunshine stock is listed on the OTC markets.

Related:  Palatin Technologies (PTN) Hits 52-Week High On Positive Development

However, the company’s management believes that an uplisting to the OTCQB is going to be important for the long-term growth strategies of Sunshine Biopharma. It should be noted that such an uplisting is going to make it possible for institutional investors to invest in Sunshine.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.